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The Angel's Trumpet Tree, or nana honua as it is called by 
Hawaiians, ' is prized as an ornamental tree because of its large, 
fragrant, trumpet-shaped flowers. A young man developed an 
acute anticholinergic syndrome from ingesting a tea brewed 
from Angel's Trumpet Tree. Because the tree grows so readily in 
Hawaii, health care providers need to be aware of the clinical 
presentation and treatment of this unusual etiology of acute 
delirium. 
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Case History 
A 19-year old man was brought to the emergency room at 
Tripier Army Medical Center at 11:30 am when his friends 
observed his confusion and repetitive cigarette-lighting behav-
ior the morning following ingestion of tea made from a plant 
collected on the island of Hawaii. The plant was tentatively 
identified as a Datura species by the Poison Control Center from 
a verbal description of the plant after it was confiscated by the 
Military Police. Treatment was initiated based on this informa-
tion. The plant was subsequently confirmed to be the Angel's 
Trumpet Tree by the University of Hawaii Botany Division. 
The patient said he had consumed 12 ounces of a tea brewed 
from the Angel's Trumpet Tree over a 1 0-minute period at 
approximately 1 :30 am on the day of admission. After 45 
minutes, the patient noted emotional lability: happiness and 
dancing with Reggae music, anger with heavy metal music, and 
sadness and crying with slow dance music. He also complained 
of difficulty with coordination: spilling coffee, putting a ciga-
rette to his cheek when he intended to put it into his mouth, 
inability to walk in a straight line; talking loudly; and having 
hallucinations about propeller blades. He was confused and 
disoriented. After several hours, he went home to sleep. He 
awoke at 6:30 am with headache, feeling warm and flushed, 
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cotton mouth, inability to focus his vision, stumbling while 
walking, and reaching for a cigarette that was not there. In the 
emergency room, he did not remember how he got to the 
hospital. Two other friends consumed a smaller quantity of the 
tea and did not report symptoms. The patient denied concurrent 
use of illicit drugs at the party. 
The patient was given naloxone 2 mg intravenous pyelogram 
and 60 grams of charcoal in 60 ml of 20% sorbitol and was 
admitted to a telemetry ward for observation. 
His past medical history was remarkable for a history of 
alcohol consumption, 5 drinks/week, cigarette use, 10 pack-
years, and past illicit drug use: marijuana, lysergic acid 
diethylamide (LSD), and cocaine. His family history was posi-
tive for cancer, diabetes mellitus, and alcoholism, 
On physical examination, the vital signs were blood pressure: 
119/60; pulse: 50 bpm; respirations: 16; temperature: 98.4°F. He 
was a well-developed, well-nourished man with intermittent 
periods of confusion (wondering if his father had brought him to 
the hospital, but then realizing his father lived in Virginia and 
could not have done so) and restlessness (standing up anxiously 
several times but denying anything was wrong). His pupils were 
dilated at 7 mm with a sluggish constriction response to light 
(5 mm); mucous membranes were dry; bowel sounds were 
decreased; skin was dry and warm with flushing of the face and 
neck. The remainder of the physical examination was normal. 
Blood chemistries, complete blood count, and urinalysis were 
normal. Blood alcohol was undetectable. Urine drug screen was 
negative. The EKG showed sinus bradycardia at 52 bpm. 
The patient gradually improved and was discharged after 24 
hours of observation. All symptoms except mild blurring of 
vision resolved. At discharge, the physical examination showed 
a pulse of 47 bpm, dilated pupils at 6 mm, and dry skin. Follow-
up was arranged in the Tri-Services Alcohol Recovery Facility 
(TRI-SARF) and with his primary care physician. 
Discussion 
Due to the synthesis of atropine (dl-hyoscyamine) and scopo-
lamine (!-hyoscine), several plant species in the genus Datura 
have long been used by humans for medicinal and hallucino-
genic purposes. 2 The most well-known species in North America 
is Datura stramonium or jimsonweed. Two species are found in 
Hawaii, D. arborea and D. candida, the latter being the more 
common; both are known locally as the Angel's Trumpet Tree. 3 
Scopolamine is the principal active compound in all species of 
Datura. 2 The amount of scopolamine, atropine, and other minor 
alkaloids is similar among species. In the report published by 
Hall et al, the flower of D. sauveolens, a species included in the 
section Brugmansia with D. candida, contained approximately 
0.20 mg of atropine and 0.65 mg of scopolamine.4 
The symptoms and signs of Datura intoxication are due to 
competition by scopolamine and atropine with acetylcholine for 
a common binding site on muscarinic receptors located in 
exocrine glands, smooth and cardiac muscle, ganglia, intramu-
ral neurons, and the central nervous system. As such, they are 
known as muscarinic cholinergic blocking agents. When hu-
mans are exposed to graded doses of atropine, the constellation 
of organ manifestations occur in a predictable hierarchy: block-
ade of sweat, salivary, and bronchial gland secretion; mydriasis, 
loss of accommodation, and tachycardia; inhibition of 
micturation, and decreased tone and motility of the gastrointes-
tinal tract; and impaired gastric acid secretion and motility. 5 The 
central nervous system effects of toxic doses of atropine include 
restlessness, irritability, disorientation, hallucinations, or de-
lirium. In severe cases, coma, paralysis, respiratory failure, 
circulatory collapse, and death can occur. Due to greater perme-
ation of the blood-brain barrier, central nervous system effects 
are seen with therapeutic doses of scopolamine; these include 
drowsiness, memory loss, fatigue, and euphoria. Higher doses 
of scopolamine produce similar central nervous system effects 
as atropine. The following metaphor has been taught to genera-
tions of clinicians to help them remember this clinical syn-
drome: "Hot as a hare, blind as a bat, dry as a bone, red as a beet, 
and mad as a hatter." 
The clinical presentation of the patient in this case report is 
consistent with other studies and illustrates several differences 
in the pharmacology of scopolamine as compared to atropine. 
The symptoms of feeling warm and flushed, headache, 
xerostomia, and blurred vision, and the signs of mydriasis, 
sluggish and incomplete pupillary constriction to light, dry 
mucous membranes, decreased bowel sounds, warm, dry skin, 
and flushing of the face and neck are all explained by peripheral 
muscarinic receptor blockade. The occurrence of severe central 
nervous system signs and symptoms of emotional lability, 
incoordination, hallucinations about propeller blades, restless-
ness, confusion, and disorientation with peripheral manifesta-
tions confirm chemical analyses demonstrating scopolamine to 
be the principal agent. The presence of bradycardia, an unusual 
feature of an anticholinergic syndrome, can be explained by the 
effect of scopolamine on MI receptors of postganglionic para-
sympathetic neurons, thus abolishing the inhibitory effect of 
synaptic acetylcholine on neurotransmitter release. 5 The persis-
tence of blurred vision at hospital discharge demonstrates the 
effect of atropine and scopolamine to cause prolonged impair-
ment of pupillary and accommodation reflexes; full recovery 
may not occur for 7 to 12 days. 
The treatment of cases of Datura intoxication is primarily 
supportive. Due to impaired peristalsis, all candidates consid-
ered for hospitalization should be given activated charcoal to 
limit absorption. Physostigmine, 1 mg to 4 mg, given by slow 
intravenous injection rapidly abolishes the systemic effects of 
anticholinergic drugs.6 Due to the short half-life of physostig-
mine, the dose may have to be repeated every 1 to 2 hours in 
symptomatic patients. 
While the acute anticholinergic syndrome is uncommon, the 
diagnosis is usually made by the astute clinician on the basis of 
the constellation of patient signs and symptoms. Treatment is 
easily administered and complete recovery is the rule. Recent 
reports underscore the potential for intentional misuse and 
accidental poisoning from Datura species.7-8 Emergency room 
and primary care physicians in Hawaii need to be aware of the 
similar potential with the ornamental Angel's Trumpet Tree. 
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